Being the ultimate travel companion of a patient with uterine leiomyosarcoma.
doublet toxicity
morcellation
trabectedin
uterine leiomyosarcoma
uterine myomas
Journal
Future oncology (London, England)
ISSN: 1744-8301
Titre abrégé: Future Oncol
Pays: England
ID NLM: 101256629
Informations de publication
Date de publication:
Sep 2022
Sep 2022
Historique:
pubmed:
29
9
2022
medline:
22
10
2022
entrez:
28
9
2022
Statut:
ppublish
Résumé
Uterine fibroids are difficult to distinguish from malignant masses using standard ultrasonography; and morcellation carries the risk of disseminating occult cancer in a small but relevant group of women with an undetected uterine malignancy. In this context, we follow the progress of a woman diagnosed with uterine leiomyosarcoma after suboptimal initial surgery for an assumed fibroid. Evidence is reviewed that guided multidisciplinary tumor board decisions about optimal management approaches after local seeding and development of distant metastases, and informed treatment selection at each line of therapy. As the case study illustrates, choice of treatment for advanced soft tissue sarcomas frequently involves finding an appropriate balance between the efficacy and toxicity of available options, aiming to allow patients to maintain their normal lives.
Identifiants
pubmed: 36169665
doi: 10.2217/fon-2022-0637
doi:
Types de publication
Review
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
17-23Subventions
Organisme : PharmaMar